Report
Nikolaas Faes

APHRIA BUY | CAD26 vs. CAD25 Aphria One is now fully licensed

APHRIA BUY | CAD26 vs. CAD25

Aphria One is now fully licensed

Updating financial model
Aphria One is now fully licensed
CC Pharma acquisition a big step forward in a German strategy
Underlying
Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Nikolaas Faes

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch